Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
321 institutional managers report a position in Adma Biologics, Inc. worth $1.7B between them, filed on form 13F for the quarter ending 2026-06-30. 32 of them hold 80% of it, the largest being BlackRock, Inc. at 18.51%.
296 more managers in the register
32 managers hold 80% of the $1.7B institutional base. The other 289 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Rubric Capital Management LP, Caption Management, LLC, Stonepine Capital Management, LLC +2 more · 4.51% of ADMA, 21.94% of HRTX
via First Trust Advisors LP, Ranger Investment Management, L.P., Kennedy Capital Management, Inc. +4 more · 3.76% of ADMA, 4.78% of LMAT
via Rubric Capital Management LP, Principal Financial Group Inc, Federated Investors Inc +5 more · 4.51% of ADMA, 5.82% of MCY
via Capital Research Global Investors, First Trust Advisors LP, Qube Research & Technologies Ltd +1 more · 4.22% of ADMA, 18.24% of TAK
via Rubric Capital Management LP, Nantahala Capital Management, LLC, Principal Financial Group Inc +2 more · 4.51% of ADMA, 6.22% of AMRX
via Capital Research Global Investors, Kennedy Capital Management, Inc., Principal Financial Group Inc +2 more · 4.22% of ADMA, 7.15% of ADUS
Managers holding a meaningful stake in ADMA also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
ADMA (Adma Biologics, Inc.) has 4 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: GRFS +0.20%, in industrials & materials.
Adma Biologics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 8.60 · gapped above the open, never looked back. High/low 9.17 at 5:30 am ET, 8.60 at 3:45 pm ET.